Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSTO
3551
PUT
DELISTED
Vista Outdoor Inc.
VSTO
| $5.42M | ﹤0.01% |
194,400
-103,800
| -35% | -$3.7M |
|
3552
PUT
Tandem Diabetes Care
TNDM
$1.58B
| $5.42M | ﹤0.01% |
91,600
+37,000
| +68% | +$3.04M |
|
3553
M/I Homes
MHO
$3.85B
| $5.42M | ﹤0.01% |
136,660
-2,663
| -2% | -$116K |
|
3554
PUT
Incyte
INCY
$24.4B
| $5.42M | ﹤0.01% |
71,300
-99,500
| -58% | -$7.56M |
|
3555
Scotiabank
BNS
$112B
| $5.41M | ﹤0.01% |
91,433
-24,888
| -21% | -$1.61M |
|
|
MRTX
3556
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.41M | ﹤0.01% |
80,600
+49,900
| +163% | +$3.17M |
|
3557
Transmedics
TMDX
$3.07B
| $5.41M | ﹤0.01% |
+172,010
| New | +$4.59M |
|
3558
CALL
AGCO
AGCO
$7.1B
| $5.41M | ﹤0.01% |
54,800
-57,100
| -51% | -$7.11M |
|
|
GNAC
3559
DELISTED
Group Nine Acquisition Corp. Class A Common stock
GNAC
| $5.41M | ﹤0.01% |
549,719
-400,887
| -42% | -$3.93M |
|
3560
PUT
Verisk Analytics
VRSK
$23.6B
| $5.4M | ﹤0.01% |
31,200
+27,200
| +680% | +$5.07M |
|
3561
PUT
Green Plains
GPRE
$1.09B
| $5.4M | ﹤0.01% |
198,600
-13,400
| -6% | -$419K |
|
3562
CALL
Woodside Energy
WDS
$44B
| $5.39M | ﹤0.01% |
+250,128
| New | +$5.67M |
|
3563
CALL
Sturm, Ruger & Co
RGR
$602M
| $5.38M | ﹤0.01% |
84,600
-3,200
| -4% | -$215K |
|
3564
CALL
Vanguard Total International Stock ETF
VXUS
$164B
| $5.38M | ﹤0.01% |
104,300
+59,200
| +131% | +$3.28M |
|
3565
Fresenius Medical Care
FMS
$12.7B
| $5.38M | ﹤0.01% |
215,762
+171,184
| +384% | +$5.12M |
|
3566
PUT
On Holding
ONON
$10.8B
| $5.38M | ﹤0.01% |
304,100
-150,500
| -33% | -$3.26M |
|
3567
CALL
AdvisorShares Pure US Cannabis ETF
MSOS
$930M
| $5.38M | ﹤0.01% |
519,400
-43,500
| -8% | -$646K |
|
|
ABMD
3568
CALL
DELISTED
Abiomed Inc
ABMD
| $5.37M | ﹤0.01% |
21,700
-3,800
| -15% | -$1.03M |
|
3569
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
| $5.37M | ﹤0.01% |
201,376
+109,105
| +118% | +$3.07M |
|
3570
Riskified
RSKD
$875M
| $5.37M | ﹤0.01% |
1,208,453
+146,189
| +14% | +$757K |
|
|
TPTX
3571
CALL
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $5.37M | ﹤0.01% |
+71,300
| New | +$3.17M |
|
3572
BlackLine
BL
$1.77B
| $5.36M | ﹤0.01% |
80,532
+49,772
| +162% | +$3.41M |
|
3573
VanEck Semiconductor ETF
SMH
$72.4B
| $5.36M | ﹤0.01% |
52,646
+48,548
| +1,185% | +$5.64M |
|
3574
PUT
Waters Corp
WAT
$40.5B
| $5.36M | ﹤0.01% |
16,200
+4,200
| +35% | +$1.33M |
|
3575
State Street Communication Services Select Sector SPDR ETF
XLC
$22.9B
| $5.36M | ﹤0.01% |
98,798
+40,247
| +69% | +$2.42M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.